...advance its pipeline of disease-specific mesenchymal stem cell therapies. Seoul-based investors DS Asset Management and Neoplux...

...financing Raised: $20 million Investors: Axon Ventures; Bader Sultan & Bros.; Mirae Asset Venture Investment; NeoPlux...